感染、炎症、修复

参考文献

[1]FONT M D,THYAGARAJAN B,KHANNA A K.Sepsis and septic shock-basics of diagnosis,pathophysiology and clinical decision making[J].Med Clin North Am,2020,104(4):573-585.

[2]LIU D,HUANG S Y,SUN JH,et al.Sepsis-induced immuno suppression:Mechanisms,diagnosis and current treatment options[J].Mil Med Res,2022,9(1):56.

[3]韩雪妹,王日兴.脓毒症相关持续性炎症-免疫抑制-分解代谢综合征的研究进展[J].感染、炎症、修复,2021,22(3):171-174.

[4]VINCENT J L,MARSHALL J C,NAMENDYS-SILVA S A,et al.Assessment of the worldwide burden of critical illness:The intensive care over nations(ICON)audit[J].Lancet Respir Med,2014,2(5):380-386.

[5]VAN VUGHT L A,KLOUWENBERG P M K,SPITONI C,et al.Incidence,risk factors,and attributable mortality of secondary infections in the intensive care unit after admission for sepsis[J].JAMA,2016,315(14):1469-1479.

[6]MOHSIN M,TABASSUM G,AHMAD S,et al.The role of mitophagy in pulmonary sepsis[J].Mitochondrion,2021,59:63-75.

[7]SAKR Y,MOREIRA C L,RHODES A,et al.The impact of hospital and ICU organizational factors on outcome in critically ill patients:Results from the extended prevalence of infection in intensive care study[J].Crit Care Med,2015,43(3):519-526.

[8]林洪远,姚咏明,从脓毒症术语的变迁认识脓毒症发生本质[J].感染、炎症、修复,2018,19(3):131-135.

[9]SPADARO S,FOGAGNOLO A,CAMPO G,et al.Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients[J].Crit Care,2021,25(1):74.

[10]MASON R J.Biology of alveolar typeⅡcells[J].Respirology,2006,11(Suppl S):12-15.

[11]DE SOUZA XAVIER COSTA N,DA COSTA SIGRIST G,SCHALCH A S,et al.Lung tissue expression of epithelial injury markers is associated with acute lung injury severity but does not discriminate sepsis from ARDS[J].Respir Res,2024,25(1):129.

[12]HERZOG EL,BRODY AR,COLBY T V et al.Knowns and unknowns of the alveolus[J].Proc Am Thorac Soc,2008,5(7):778-782.

[13]DOBBS L G,JOHNSON M D,VANDERBILT J,et al.The great big alveolar TI cell:Evolving concepts and paradigms[J].Cell Physiol Biochem,2010,25(1):55-62.

[14]WU Y,MA J,WOODS P S,et al.Selective targeting of alveolar type II respiratory epithelial cells by anti-surfactant protein-C antibodyconjugated lipoplexes[J].J Control Release,2015,203:140-149.

[15]WHITSETT J A,WERT S E and WEAVER T E.Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease[J].Annu Rev Med,2010,61:105-119.

[16]MARCONETT C N,ZHOU B,RIEGER M E,et al.Integrated transcriptomic and epigenomic analysis of primary human lung epithelial cell differentiation[J].PLoS Genet,2013,9(6):e1003513.

[17]HUANG X,CAO M,XIAO Y.Alveolar macrophages in pulmonaryalveolar proteinosis:origin,function,and therapeutic strategies[J].Front Immunol,2023,14:1195988.

[18]AUTILIO C,PEREZ-GIL J.Understanding the principle biophysics concepts of pulmonary surfactant in health and disease[J].Arch Dis Child Fetal Neonatal Ed,2019,104(4):F443-F451.

[19]MATTHAY M A.Resolution of pulmonary edema:Thirty years of progress[J].Am J Respir Crit Care Med,2014,189(11):1301-1308.

[20]SERRANO A G,PEREZ-GIL J.Protein-lipid interactions and surface activity in the pulmonary surfactant system[J].Chem Phys Lipids,2006,141(1-2):105-118.

[21]BERNHARD W.Lung surfactant:Function and composition in the context of development and respiratory physiology[J].Ann Anat,2016,208:146-150.

[22]REID K B.Functional roles of the lung surfactant proteins SP-A and SP-D in innate immunity[J].Immunobiology,1998,199(2):200-207.

[23]TAKAHASHI H,SANO H,CHIBA H,et al.Pulmonary surfactant proteins A and D:Innate immune functions and biomarkers for lung diseases[J].Curr Pharm Des,2006,12(5):589-598.

[24]KUROKI Y,TAKAHASHI M,NISHITANI C.Pulmonary collectins in innate immunity of the lung[J].Cell Microbiol,2007,9(8):1871-1879.

[25]BARKAUSKAS C E,CRONCE M J, RACKLEY C R,et al.Type 2alveolar cells are stem cells in adult lung[J].J Clin Invest,2013,123(7):3025-3036.

[26]ROCK J R,HOGAN B L.Epithelial progenitor cells in lung development,maintenance,repair,and disease[J].Annu Rev Cell Dev Biol,2011,27:493-512.

[27]KOSMIDER B,LIN C R,VLASENKO L,et al.Impaired nonhomologous end joining in human primary alveolar typeⅡcells in emphysema[J].Sci Rep,2019,9(1):920.

[28]HOGAN B L,BARKAUSKAS C E,CHAPMAN H A,et al.Repair and regeneration of the respiratory system:C omplexity,plasticity,and mechanisms of lung stem cell function[J].Cell Stem Cell,2014,15(2):123-138.

[29]HAN S,BUDINGER G R S,GOTTARDI C J.Alveolar epithelial regeneration in the aging lung[J].J Clin Invest,2023,13 3(20):e170504.

[30]BOS L D J,WARE L B.Acute respiratory distress syndrome:Causes,pathophysiology,and phenotypes[J].Lancet,2022,400(10 3 5 8):1145-1156.

[31]BACHOFEN M,WEIBEL E R.Structural alterations of lung parenchyma in the adult respiratory distress syndrome[J].Clin Chest Med,1982,3(1):35-56.

[32]FEIN A,GROSSMAN R F, JONES J G,et al.The value of edema fluid protein measurement in patients with pulmonary edema[J].Am J Med,1979,67(1):32-38.

[33]ENGLERT J A,MACIAS A A,AMADOR-MUNOZ D,et al.Isoflurane Ameliorates Acute Lung Injury by Preserving Epithelial Tight Junction Integrity[J].Anesthesiology,2015,123(2):377-3 88.

[34]THORLEY A J,GRANDOLFO D,LIM E,et al.Innate immune responses to bacterial ligands in the peripheral human lung--role of alveolar epithelial TLR expression and signalling[J].PLoS One,2011,6(7):e21827.

[35]CIESIELSKA A,MATYJEK M,KWIATKOWSKA K.TLR4 and CD 14 trafficking and its influence on LPS-induced pro-inflammatory signaling[J].Cell Mol Life Sci, 2021,78(4):1233-1261.

[36]KAGAN J C,SU T,HORNG T,et al.TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta[J].Nat Immunol,2008,9(4):361-368.

[37]ZANONI I,OSTUNI R,MAREK L R,et al.CD14 controls the LPSinduced endocytosis of Toll-like receptor 4[J].Cell,2011,147(4):868-880.

[38]WANG Z, GUO Z, WANG X, et al.Inhibition of EZH2 ameliorates sepsis acute lung injury(SALI)and non-small-cell lung cancer(NSCLC)proliferation through the PD-L1 pathway[J].Cells,2022,11(24):395 8.

[39]THORLEY A J, FORD P A,GIEMBYCZ M A,et al.Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar typeⅡepithelial cells and macrophages[J].J Immunol,2007,178(1):463-473.

[40]YANG J,WANG Y,LIU H,et al.C2-ceramide influences alveolar epithelial barrier function by downregulating Zo-1,occludin and claudin-4expression[J].Toxicol Mech Methods,2017,27(4):293-297.

[41]SIM T Y,HARITH H H,THAM C L,et al.The protective effects of a synthetic geranyl acetophenone in a cellular model of TNF-alpha-induced pulmonary epithelial barrier dysfunction[J].Molecules,2018,23(6):1355.

[42]YI L,CHEN Y,ZHANG Y,et al.Deleting fibroblast growth factor 2in macrophages aggravates septic acute lung injury by increasing M1polarization and inflammatory cytokine secretion[J].Mol Biomed,2024,5(1):50.

[43]GAO M,ZHU X,GAO X,et al.Kaempferol mitigates sepsis-induced acute lung injury by modulating the SphK1/S1P/S1PR1/MLC2 signaling pathway to restore the integrity of the pulmonary endothelial cell barrier[J].Chem Biol Interact,2024,398:111085.

[44]DEJANA E,TOURNIER-LASSERVE E,WEINSTEIN B M.The control of vascular integrity by endothelial cell junctions:Molecular basis and pathological implications[J].Dev Cell,2009,16(2):209-221.

[45]LI X,JAMAL M,GUO P,et al.Irisin alleviates pulmonary epithelial barrier dysfunction in sepsis-induced acute lung injury via activation of AMPK/SIRT1 pathway s[J].Biomed Pharmacother,2019,118:109363.

[46]SCHIFANELLA L,ANDERSON J,WIEKING G,et al.The Defenders of the alveolus succumb in COVID-19 pneumonia to SARS-CoV-2 and necroptosis,pyroptosis,and panoptosis[J].J Infect Dis,2023,227(11):1245-1254.

[47]ZHANG T,LI M,ZHAO S,et al.CaMK4 promotes acute lung injury through NLRP3 inflammasome activation in typeⅡalveolar epithelial cell[J].Front Immunol,2022,13:890710.

[48]SHI J,ZHAO Y,WANG Y,et al.Inflammatory caspases are innate immune receptors for intracellular LPS[J].Nature,2014,514(7521):187-192.

[49]WANG K,SUN Q,ZHONG X,et al.Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis[J].Cell,2020,180(5):941-955,e920.

[50]LIU X,ZHANG Z,RUAN J,et al.Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores[J].Nature,2016,535(7610):153-158.

[51]LI H,NIU X,SHI H,et al.circHECTD1 attenuates apoptosis of alveolar epithelial cells in acute lung injury[J].Lab Invest,2022,102(9):945-956.

[52]LI K,HE Z,WANG X,et al.Apigenin C-glycosides of microcos paniculata protects lipopolysaccharide induced apoptosis and inflammation in acute lung injury through TLR4 signaling pathway[J].Free Radic Biol Med,2018,124:163-175.

[53]WARE L B,MATTHAY M A.Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratorydistress syndrome[J].Am J Respir Crit Care Med,2001,163(6):1376-1383.

[54]EISNER M D,PARSONS P,MATTHAY M A,et al.Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury[J].Thorax,2003,58(11):983-988.

[55]RYU J K,KIM S J,RAH S H,et al.Reconstruction of LPS transfer cascade reveals structural determinants within LBP,CD 14,and TLR4-MD2 for efficient LPS recognition and transfer[J].Immunity,2017,46(1):38-50.

[56]WARE L B,KOYAMA T,BILLHEIMER D D,et al.Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury[J].Chest,2010,137(2):288-296.

[57]PARSONS P E,EISNER M D,THOMPSON B T,et al.Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury[J].Crit Care Med,2005,33(1):1-6,discussion 230-232.

[58]BERSTEN A D,DOYLE I R,DAVIDSON K G,et al.Surfactant composition reflects lung overinflation and arterial oxygenation in patients with acute lung injury[J].Eur Respir J,1998,12(2):301-308.

[59]KERR C L,VELDHUIZEN R A,LEWIS J F.Effects of high-frequency oscillation on endogenous surfactant in an acute lung injury model[J].Am J Respir Crit Care Med,2001,164(2):237-242.

[60]ZENG L,YANG X T,LI H S,et al.The cellular kinetics of lung alveolar epithelial cells and its relationship with lung tissue repair after acute lung injury[J].Respir Res,2016,17(1):164.

[61]SHAO Y,ZHOU F,HE D,et al.Overexpression of CXCR7 promotes mesenchymal stem cells to repair phosgene-induced acute lung injury in rats[J].Biomed Pharmacother,2019,109;1233-1239.

[62]LI Y,SHI X,YANG L,et al.Hypoxia promotes the skewed differentiation of umbilical cord mesenchymal stem cells toward type II alveolar epithelial cells by regulating microRNA-145[J].Gene,2017,630:68-75.

[63]ZHOU Y,LI P,GOODWIN A J,et al.Exosomes from endothelial progenitor cells improve outcomes of the lipopolysaccharide-induced acute lung injury[J].Crit Care,2019,23(1):44.

[64]QIN H,ZHAO A.Mesenchymal stem cell therapy for acute respiratory distress syndrome:From basic to clinics[J].Protein Cell,2020,11(10):707-722.

[65]IONESCU L,BYRNE R N,VAN HAAFTEN T,et al.Stem cell conditioned medium improves acute lung injury in mice:In vivo evidence for stem cell paracrine action[J].Am J Physiol Lung Cell Mol Physiol,2012,303(11):L967-L977.

[66]BERNARD O,JENY F, UZUNHAN Y,et al.Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating HIF and ROS hypoxic signaling[J].Am J Physiol Lung Cell Mol Physiol,2018,314(3):L360-L371.

[67]CHEN X X, TANG L,HAN Z H,et al.Coculture with bone marrow-derived mesenchymal stem cells attenuates inflammation and apoptosis in lipopolysaccharide-stimulated alveolar epithelial cells via enhanced secretion of keratinocyte growth factor and angiopoietin-1modulating the Toll-like receptor-4 signal pathway[J].Mol Med Rep,2019,19(3):1891-1902.

[68]KRASNODEMBSKAYA A,SONG Y, FANG X,et al.Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37[J].Stem Cells,2010,28(12):2229-2238.

[69]GUPTA N,KRASNODEMBSKAYA A,KAPETANAKI M,et al.Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia Coli.pneumonia[J].Thorax,2012,67(6):533-539.

[70]SUNG D K,CHANG Y S,SUNG S I,et al.Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta-defensin-2 via toll-like receptor 4 signalling[J].Cell Microbiol,2016,18(3):424-436.

[71] RUDD K E,JOHNSON S C,AGESA K M,et al.Global,regional,and national sepsis incidence and mortality,1990-2017:Analysis for the Global Burden of Disease Study[J].Lancet,2020,395(10219):200-211.

[72]NOVA Z, SKOVIEROVA H,STRNADEL J,et al.Short-term versus long-term culture of A549 Cells for evaluating the effects of lipopolysaccharide on oxidative stress,surfactant proteins and cathelicidin LL-37[J].Int J Mol Sci,2020,21(3):1148.

[73]CHARY A,GROFF K,STUCKI A O,et al.Maximizing the relevance and reproducibility of A549 cell culture using FB S-free media[J].Toxicol In Vitro,2022,83:105423.

[74]HAN X,NA T,WU T,et al.Human lung epithelial BEAS-2B cells exhibit characteristics of mesenchymal stem cells[J].PLoS One,2020,15(1):e0227174.

[75]NIGHOT M,AL-SADI R,GUO S,et al.Lipopolysaccharide-induced increase in intestinal epithelial tight permeability is mediated by tolllike receptor 4/myeloid differentiation primary response 88(MyD88)activation of myosin light chain kinase expression[J].Am J Pathol,2017,187(12):2698-2710.

[76]CHUANG C Y,CHEN T L,CHERNG Y G,et al.Lipopolysaccharide induces apoptotic insults to human alveolar epithelial A549 cells through reactive oxygen species-mediated activation of an intrinsic mitochondriondependent pathway[J].Arch Toxicol,2011,85(3):209-218.

[77]ZHAO J,LI X,ZOU M,et al.miR-135a inhibition protects A549 cells from LPS-induced apoptosis by targeting Bcl-2[J].Biochem Biophys Res Commun,2014,452(4):951-957.

[78]PEI H,CHEN J, QU J,et al.S100A9 exacerbates sepsis-induced acute lung injury via the IL17-NFkappaB-caspase-3 signaling pathway[J].Biochem Biophys Res Commun,2024,710:149832.

[79]HUANG C,ZHENG H,HE W,et al.Ghrelin ameliorates the human alveolar epithelial A549 cell apoptosis induced by lipopolysaccharide[J].Biochem Biophys Res Commun,2016,474(1):83-90.

[80]LI S, GUO L,QIAN P,et al.Lipopolysaccharide induces autophagic cell death through the PERK-dependent branch of the unfolded protein response in human alveolar epithelial A549 cells[J].Cell Physiol Biochem,2015,36(6):2403-2417.

[81]DING Z,WU X,WANG Y,et al.Melatonin prevents LPS-induced epithelial-mesenchymal transition in human alveolar epithelial cells via the GSK-3beta/Nrf2 pathway[J].Biomed Pharmacother,2020,132:110827.